ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01297101
Recruitment Status : Temporarily not available
First Posted : February 16, 2011
Last Update Posted : February 16, 2011
Sponsor:
Collaborators:
Guangdong General Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Information provided by:
Shanghai Chest Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Temporarily not available
  Primary Completion Date : No date given
  Study Completion Date : No date given